Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell Carcinoma
Ruba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, David M Hyams, Constantin A Dasanu · 2024
Read Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell Carcinoma by Ruba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, David M Hyams, Constantin A Dasanu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11693926.txt.
Description
Alchaikh Hassan and co-authors present a 2024 case report on an 81-year-old man with advanced lip cancer. His lower lip squamous cell cancer sat on the vermillion, the red part of the lip. A first immune drug, cemiplimab, failed to shrink it. Doctors then gave cetuximab, an antibody drug, before planned surgery.
After that treatment, removed tissue showed a complete response, with no cancer left under the microscope. The man stayed under watch, with checks of skin and mouth surfaces. At twenty-four weeks he had no sign of return and liked the look of the repair. The authors claim a first for this setting and urge trials.
Catalog record
| CREATOR | Ruba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, David M Hyams, Constantin A Dasanu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 14 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |